Infamous ‘Pharma Bro’ Martin Shkreli slammed billionaire Mark Cuban’s new online pharmacy for making what he says are ‘largely false’ claims about its cost savings.
Shkreli – once dubbed the ‘most hated man in America’ for jacking up the price of a life-saving drug 5,000 percent – launched his on Monday with a snarky post criticizing Cuban’s company, Cost Plus Drugs.
He accused the billionaire’s internet pharmacy of not being transparent about medication and shipping costs to make it appear as if savings were greater.
The convicted fraudster also deemed Cost Plus Drugs a doomed venture that ‘will not be profitable’ and questioned if Cuban will ‘keep it alive for his ego’s sake.’
DailyMail.com has sought comment from Cuban.
Shkreli, who once led Vyera Pharmaceuticals, became infamous in 2015 for jacking up the price of life-saving AIDS drug Daraprim from $13.50 to $750.
He was convicted of two counts of securities fraud and a single count of conspiracy in 2017 and sentenced to seven years in prison in 2018. Shkreli was released early in May and transported to a halfway house where he will be held until August.
Infamous ‘Pharma Bro’ Martin Shkreli (left) slammed billionaire Mark Cuban’s new online pharmacy for making ‘largely false’ claims about its cost savings. The convicted fraudster also deemed Cost Plus Drugs a doomed venture that ‘will not be profitable’ and questioned if Cuban (right) will ‘keep it alive for his ego’s sake’
In his post Monday, the so-called Pharma Bro claimed Cost Plus Drugs was inflating the amount of money customers would save on their medications by utilizing its online pharmacy.
He alleged that Imatinib, a drug used to treat cancer patients, is available to consumers in a 30-day supply for ‘as little as $130.’
Cost Plus Drugs is selling the product for $39, not including shipping, according to screenshots from the pharmacy’s website that Shkreli shared on his blog.
The company’s website also allegedly states the retail price for the medication is $9,657.30, a reported savings of 99 percent.
Shkreli claims he compared the cost of the drug to going rates on other discount internet pharmacies, such as DiRx, GeniusRx and GoodRx, and found it available for around $130. He alleges Cost Plus Drugs customers are actually only saving around 60 percent on Imatinib.
‘For a company promising transparency, I would include the average competitors price,’ he wrote. ‘This pharmacy is listing the old price of Imatinib from the brand company, which no one takes anymore.
‘Cuban’s pharmacy should display an apples-to-apples cost savings. So should GoodRx. Transparency, right?’
Cost Plus Drugs is selling Imatinib, a drug used to treat cancer patients, for $39 – not including shipping, according to screenshots from the pharmacy’s website that Shkreli shared
Shkreli claims he compared the cost of the drug to going rates on other discount internet pharmacies, such as DiRx, GeniusRx and GoodRx, and skiptheplay found it available for around $130
Shkreli also alleged Cost Plus Drugs failed to save customers any money whatsoever on albendazole, which is used to treat an infection caused by tapeworms.
He claims Cuban’s pharmacy sells two albendazole pills for $33 plus tax and shipping costs.
Comparatively, customers can purchase two pills of the medication for $50 at ‘multiple pharmacies,’ Shkreli wrote.
He also claims Cost Plus Drugs disclosed the retail price of the medication was $437.60, promoting a cost savings of 90 percent.
‘No savings at all when figuring in shipping,’ he said, before adding that patients being treated with albendazole need to ‘take this medicine ASAP’ so it would ‘be cheaper to just go to the pharmacy’ in-person.
Shkreli also alleged Cost Plus Drugs failed to save customers any money whatsoever on albendazole, which is used to treat an infection caused by tapeworms
Shkreli then went on the allege purchasing ‘average joe’ medications from Cuban’s company costs consumers the same or more than going to a traditional retail pharmacy.
‘MC Pharmacy’s Lipitor at $3.60 for 30 10mg is the same price as some retail pharmacies when including shipping costs,’ he argued. ‘Wegman’s and Price Chopper are actually cheaper, while CVS and Walgreen’s are a bit more ($10) expensive.’
He added that Amlodipine, a calcium channel blocker, has a ‘roughly similar price profile’ and there are a ‘handful of other online/mail order pharmacies’ that have ‘extremely similar’ prices to Cost Plus Drugs.
He then alleged that purchasing anti-diabetic medication metformin from Cuban’s pharmacy is more expensive, at $8.90, than getting it from Walmart for $3 and Walgreens and CVS for $8.
‘In general, retail pharmacy is a difficult business. Having to staff pharmacists interacting with physicians is expensive, renting high traffic locations and other expenses result in a plodding low-margin space,’ Shkreli wrote.
‘Online pharmacies don’t have the footprint costs but replace them with digital infrastructure and shipping costs. Expedited shipping on Cuban’s website is $15, which would further eat into cost savings of the few competitive situations I found, and simply make it more expensive than taking a trip to the pharmacy in most cases.’
DailyMail.com verified the costs of Imatinib, albendazole, Lipitor, Amlodipine and metformin on Cost Plus Drugs.
With the exception of metformin – which he reported costs over $8 although it’s listed on Cost Plus Drugs between $3.90 and $5.70 per order – Shkreli’s reported costs were accurate.
We were unable to confirm his reported prices at GoodRX as drug costs on the app vary based on pharmacy location.
Shkreli then went on the allege purchasing ‘average joe’ medications from Cuban’s company costs consumers the same or more than going to a traditional retail pharmacy
Shkreli, despite having claimed he had ‘no interest in engaging in a personal attack on anyone’ with his post, then seemingly criticized Cuban’s character.
He argued the business model under which Cost Plus Drugs operates ‘sucks’ and ‘is not new’ or ‘special.’
‘Paying cash for generics has been possible through several competitors of Cuban’s for some time now,’ he penned.
‘I don’t see any special sauce or any special prices relative to those players, for the small segment of patients who are uninsured and don’t qualify for Medicaid.’
He added: ‘It is not hard to get publicity when you’re Cuban. Publicity is easier than creating a lasting business, however.
‘I think after a year or two of operating reality, this pharmacy will not be profitable. Whether Cuban will keep it alive for his ego’s sake is up to him, but I see no real profit potential for him in the cutthroat world of pharmacy.’
Shkreli (pictured in 2015), who once led Vyera Pharmaceuticals, became infamous for jacking up the price of life-saving AIDS drug Daraprim from $13.50 to $750. He was convicted of two counts of securities fraud and a single count of conspiracy in 2017
Cost Plus Drugs launched in January with the goal of ‘making medication affordable for all.’ Mark Cuban is pictured in a pharmacy promo